DOAJ Open Access 2023

Emerging regenerative medicine for hemorrhagic stroke: An update on stem cell therapies

Molly Monsour Cesario V. Borlongan

Abstrak

Hemorrhagic stroke (HS) is a disastrous occurrence with high mortality rates, however, there are no established treatments for this pathology. Given recent advances in stem cell therapies, concerted research efforts have elucidated the therapeutic potential of stem cells in treating HS. In 2020, our group reviewed the use of SCs in regulating the neuroinflammatory reactions which occur after HS.1 This review will build on that work, highlighting more recent advancements in the field of SC treatments for HS. Ultimately, with greater focus in this area of research, innovative SC therapies can be optimized in preclinical studies and soon be transferred to clinical applications for HS therapeutics.

Penulis (2)

M

Molly Monsour

C

Cesario V. Borlongan

Format Sitasi

Monsour, M., Borlongan, C.V. (2023). Emerging regenerative medicine for hemorrhagic stroke: An update on stem cell therapies. https://doi.org/10.1016/j.hest.2022.07.001

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1016/j.hest.2022.07.001
Informasi Jurnal
Tahun Terbit
2023
Sumber Database
DOAJ
DOI
10.1016/j.hest.2022.07.001
Akses
Open Access ✓